Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PALISADE BIO, INC. Director's Dealing 2010

Sep 20, 2010

35274_dirs_2010-09-20_c37036c4-4b66-427b-8ae7-35069f86f67f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2010-09-16

Reporting Person: OLDAKER WILLIAM CLYDE (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-09-16 Common Stock P 7500 $2.32 Acquired 86800 Direct
2010-09-16 Common Stock P 2500 $2.31 Acquired 89300 Direct